185 related articles for article (PubMed ID: 34936684)
1. SARS-CoV-2 spike-specific memory B cells express higher levels of T-bet and FcRL5 after non-severe COVID-19 as compared to severe disease.
Reyes RA; Clarke K; Gonzales SJ; Cantwell AM; Garza R; Catano G; Tragus RE; Patterson TF; Bol S; Bunnik EM
PLoS One; 2021; 16(12):e0261656. PubMed ID: 34936684
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 spike-specific memory B cells express markers of durable immunity after non-severe COVID-19 but not after severe disease.
Reyes RA; Clarke K; Gonzales SJ; Cantwell AM; Garza R; Catano G; Tragus RE; Patterson TF; Bol S; Bunnik EM
bioRxiv; 2021 Sep; ():. PubMed ID: 34611662
[TBL] [Abstract][Full Text] [Related]
3. Durable SARS-CoV-2 B cell immunity after mild or severe disease.
Ogega CO; Skinner NE; Blair PW; Park HS; Littlefield K; Ganesan A; Dhakal S; Ladiwala P; Antar AA; Ray SC; Betenbaugh MJ; Pekosz A; Klein SL; Manabe YC; Cox AL; Bailey JR
J Clin Invest; 2021 Apr; 131(7):. PubMed ID: 33571162
[TBL] [Abstract][Full Text] [Related]
4. S Protein-Reactive IgG and Memory B Cell Production after Human SARS-CoV-2 Infection Includes Broad Reactivity to the S2 Subunit.
Nguyen-Contant P; Embong AK; Kanagaiah P; Chaves FA; Yang H; Branche AR; Topham DJ; Sangster MY
mBio; 2020 Sep; 11(5):. PubMed ID: 32978311
[TBL] [Abstract][Full Text] [Related]
5. Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence.
Hartley GE; Edwards ESJ; Aui PM; Varese N; Stojanovic S; McMahon J; Peleg AY; Boo I; Drummer HE; Hogarth PM; O'Hehir RE; van Zelm MC
Sci Immunol; 2020 Dec; 5(54):. PubMed ID: 33443036
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 antibody dynamics and B-cell memory response over time in COVID-19 convalescent subjects.
Achiron A; Gurevich M; Falb R; Dreyer-Alster S; Sonis P; Mandel M
Clin Microbiol Infect; 2021 Sep; 27(9):1349.e1-1349.e6. PubMed ID: 33975009
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2-specific memory B cells can persist in the elderly who have lost detectable neutralizing antibodies.
Jeffery-Smith A; Burton AR; Lens S; Rees-Spear C; Davies J; Patel M; Gopal R; Muir L; Aiano F; Doores KJ; Chow JY; Ladhani SN; Zambon M; McCoy LE; Maini MK
J Clin Invest; 2022 Jan; 132(2):. PubMed ID: 34843448
[TBL] [Abstract][Full Text] [Related]
8. Maintenance of broad neutralizing antibodies and memory B cells 1 year post-infection is predicted by SARS-CoV-2-specific CD4+ T cell responses.
Balachandran H; Phetsouphanh C; Agapiou D; Adhikari A; Rodrigo C; Hammoud M; Shrestha LB; Keoshkerian E; Gupta M; Turville S; Christ D; King C; Sasson SC; Bartlett A; Grubor-Bauk B; Rawlinson W; Aggarwal A; Stella AO; Klemm V; Mina MM; Post JJ; Hudson B; Gilroy N; Konecny P; Ahlenstiel G; Dwyer DE; Sorrell TC; Kelleher A; Tedla N; Lloyd AR; Martinello M; Bull RA;
Cell Rep; 2022 Feb; 38(6):110345. PubMed ID: 35090598
[TBL] [Abstract][Full Text] [Related]
9. Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19.
Li K; Huang B; Wu M; Zhong A; Li L; Cai Y; Wang Z; Wu L; Zhu M; Li J; Wang Z; Wu W; Li W; Bosco B; Gan Z; Qiao Q; Wu J; Wang Q; Wang S; Xia X
Nat Commun; 2020 Nov; 11(1):6044. PubMed ID: 33247152
[TBL] [Abstract][Full Text] [Related]
10. Evidence of SARS-CoV-2-Specific Memory B Cells Six Months After Vaccination With the BNT162b2 mRNA Vaccine.
Ciabattini A; Pastore G; Fiorino F; Polvere J; Lucchesi S; Pettini E; Auddino S; Rancan I; Durante M; Miscia M; Rossetti B; Fabbiani M; Montagnani F; Medaglini D
Front Immunol; 2021; 12():740708. PubMed ID: 34650563
[TBL] [Abstract][Full Text] [Related]
11. B Cell Response Induced by SARS-CoV-2 Infection Is Boosted by the BNT162b2 Vaccine in Primary Antibody Deficiencies.
Pulvirenti F; Fernandez Salinas A; Milito C; Terreri S; Piano Mortari E; Quintarelli C; Di Cecca S; Lagnese G; Punziano A; Guercio M; Bonanni L; Auria S; Villani F; Albano C; Locatelli F; Spadaro G; Carsetti R; Quinti I
Cells; 2021 Oct; 10(11):. PubMed ID: 34831138
[TBL] [Abstract][Full Text] [Related]
12. Evolution of antibody immunity to SARS-CoV-2.
Gaebler C; Wang Z; Lorenzi JCC; Muecksch F; Finkin S; Tokuyama M; Cho A; Jankovic M; Schaefer-Babajew D; Oliveira TY; Cipolla M; Viant C; Barnes CO; Bram Y; Breton G; Hägglöf T; Mendoza P; Hurley A; Turroja M; Gordon K; Millard KG; Ramos V; Schmidt F; Weisblum Y; Jha D; Tankelevich M; Martinez-Delgado G; Yee J; Patel R; Dizon J; Unson-O'Brien C; Shimeliovich I; Robbiani DF; Zhao Z; Gazumyan A; Schwartz RE; Hatziioannou T; Bjorkman PJ; Mehandru S; Bieniasz PD; Caskey M; Nussenzweig MC
Nature; 2021 Mar; 591(7851):639-644. PubMed ID: 33461210
[TBL] [Abstract][Full Text] [Related]
13. Memory B cells targeting SARS-CoV-2 spike protein and their dependence on CD4
Pušnik J; Richter E; Schulte B; Dolscheid-Pommerich R; Bode C; Putensen C; Hartmann G; Alter G; Streeck H
Cell Rep; 2021 Jun; 35(13):109320. PubMed ID: 34146478
[TBL] [Abstract][Full Text] [Related]
14. Early IgG / IgA response in hospitalized COVID-19 patients is associated with a less severe disease.
Fedele G; Russo G; Schiavoni I; Leone P; Olivetta E; Perri V; Zingaropoli MA; Ciardi MR; Pasculli P; Mastroianni CM; Stefanelli P
Diagn Microbiol Infect Dis; 2022 Jan; 102(1):115586. PubMed ID: 34742119
[TBL] [Abstract][Full Text] [Related]
15. Persistence of Antibody and Cellular Immune Responses in Coronavirus Disease 2019 Patients Over Nine Months After Infection.
Yao L; Wang GL; Shen Y; Wang ZY; Zhan BD; Duan LJ; Lu B; Shi C; Gao YM; Peng HH; Wang GQ; Wang DM; Jiang MD; Cao GP; Ma MJ
J Infect Dis; 2021 Aug; 224(4):586-594. PubMed ID: 33978754
[TBL] [Abstract][Full Text] [Related]
16. Persistent Maintenance of Intermediate Memory B Cells Following SARS-CoV-2 Infection and Vaccination Recall Response.
Pušnik J; König J; Mai K; Richter E; Zorn J; Proksch H; Schulte B; Alter G; Streeck H
J Virol; 2022 Aug; 96(15):e0076022. PubMed ID: 35862718
[TBL] [Abstract][Full Text] [Related]
17. Detection of Serum Cross-Reactive Antibodies and Memory Response to SARS-CoV-2 in Prepandemic and Post-COVID-19 Convalescent Samples.
Shrwani K; Sharma R; Krishnan M; Jones T; Mayora-Neto M; Cantoni D; Temperton NJ; Dobson SL; Subramaniam K; McNamara PS; Cunliffe NA; Turtle L; Zhang Q
J Infect Dis; 2021 Oct; 224(8):1305-1315. PubMed ID: 34161567
[TBL] [Abstract][Full Text] [Related]
18. Cross-reactive antibody against human coronavirus OC43 spike protein correlates with disease severity in COVID-19 patients: a retrospective study.
Guo L; Wang Y; Kang L; Hu Y; Wang L; Zhong J; Chen H; Ren L; Gu X; Wang G; Wang C; Dong X; Wu C; Han L; Wang Y; Fan G; Zou X; Li H; Xu J; Jin Q; Cao B; Wang J
Emerg Microbes Infect; 2021 Dec; 10(1):664-676. PubMed ID: 33734013
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells.
Cohen KW; Linderman SL; Moodie Z; Czartoski J; Lai L; Mantus G; Norwood C; Nyhoff LE; Edara VV; Floyd K; De Rosa SC; Ahmed H; Whaley R; Patel SN; Prigmore B; Lemos MP; Davis CW; Furth S; O'Keefe JB; Gharpure MP; Gunisetty S; Stephens K; Antia R; Zarnitsyna VI; Stephens DS; Edupuganti S; Rouphael N; Anderson EJ; Mehta AK; Wrammert J; Suthar MS; Ahmed R; McElrath MJ
Cell Rep Med; 2021 Jul; 2(7):100354. PubMed ID: 34250512
[TBL] [Abstract][Full Text] [Related]
20. Infection with SARS-CoV-2 primes immunological memory in human nasal-associated lymphoid tissue.
Mahallawi WH; Aljeraisi TM
Clin Immunol; 2021 Oct; 231():108850. PubMed ID: 34506944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]